News | Quality Assurance (QA) | July 08, 2019

PTW to Feature New Dosimetry Technology at AAPM 2019

Offerings will include new water phantom for MR-guided radiotherapy, modular patient and machine QA systems

The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system

The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system. Image courtesy of PTW.

July 8, 2019 — At this year’s American Association of Physicists in Medicine (AAPM) show, July 14-18 in San Antonio, Texas, PTW will exhibit its full range of dosimetry solutions for magnetic resonance-guided radiotherapy (MRgRT), beam data commissioning and stereotactic quality assurance (QA).

PTW will exhibit and demonstrate its latest technology and most recent product developments including:

  • Beamscan MR 3-D water phantom – The first 3-D water phantom for MR-guided radiotherapy, according to the company, available in two models for Elekta Unity and ViewRay MRIdian. Beamscan MR 3-D is pending U.S. Food and Drug Administration (FDA) 510(k) clearance and is not available for sale in the U.S.;
  • Beamscan 3-D water phantom – Fast to set up and easy to use for all acceptance testing and commissioning needs, now available for the Halcyon system;
  • Octavius 4-D modular patient and machine QA systems – For the latest radiotherapy techniques, including Halcyon, stereotactic radiosurgery (SRS) and MRgRT. Also introducing Octavius Detector 1600 SRS for 3-D dose verification of complex SRS/SBRT (stereotactic body radiation therapy) treatment plans;
  • Ruby phantom – A new modular stereotactic verification phantom with multiple inserts for comprehensive system QA, linear accelerator (linac) QA and patient QA:
  • StarCheck arrays – High-resolution ionization chamber arrays for comprehensive, TG-142-compliant linac QA, available in three models for standard (25 x 25 cm²), large (40 x 40 cm²) and magnetic fields;
  • microSilicon diode detector – The new silicon diode detector for small photon and all electron fields; and
  • Track-it 2.0 QA data management software – Versatile, web-based QA data management software that integrates QA data from different sources, devices and sites into a single platform.

PTW is hosting a Lunch and Learn symposium for AAPM attendees on Monday, July 15. The event will feature the following presenters:

  • Jochem Wolthaus, Ph.D., a medical physicist at the University Medical Center Utrecht, will present “The Development and Experience of the first MR-compatible 3-D Scanning Water Tank for Acceptance, Commissioning and QA measurements in an MRI-LINAC”; 
  • Dan Nicewonger, a medical physicist at the MD Anderson Cancer Center in San Antonio, will present “QA Data Flow in Modern Radiotherapy Departments”; and
  • Sharon Thompson, a medical physicist from the Maimonides Cancer Center, Brooklyn, N.Y., will present “Challenges of Beam Data Collection and Validation of Halcyon during Commissioning.”

For more information: www.ptwdosimetry.com

Related Content

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure. This picture shows a circle of hydrogel that was irradiated on the left half, which is slightly pink; whereas the right half of the gel is not irradiated and remains colorless.

News | Radiation Therapy | February 18, 2020
February 18, 2020 — More than half of all cancer patients undergo radiation therapy and the dose is critical.
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
The radiation therapy market is projected to grow in through 2026

Image courtesy of Accuray

News | Proton Therapy | February 10, 2020
February 10, 2020 — Amid technological advancement, and notable research and development activities, the global ...
SIR President Laura Findeiss, M.D., FSIR

SIR President Laura Findeiss, M.D., FSIR

News | Interventional Radiology | February 09, 2020
February 9, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the...
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...
Purdue University-discovered fluorescent markers to target and illuminate cancer during surgery, has announced the results of a multi-institutional Phase 2 clinical trial in which outcomes were improved for 26 percent of patients undergoing pulmonary resection for non-small-cell lung cancer (NSCLC)

A Purdue discovery being developed by On Target Laboratories Inc., illuminates lung cancer cells on a patient during surgery. The “fluorescent markers” help medical professionals identify and remove cancer cells during surgery and is shown to improve outcomes. The technology is beginning Phase 3 clinical trials. (Photo provided by On Target)

News | Molecular Imaging | February 06, 2020
February 6, 2020 — ...
The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy

An oxygen map image recovered from a mouse undergoing radiation therapy. The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy (red). Image courtesy of Brian Pogue, PhD

News | Radiation Therapy | February 03, 2020
February 3, 2020 — Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful.
News | Clinical Trials | February 03, 2020
February 3, 2020 — Melding the genetic and cellular analysis of tumors with how they appear in medical images could g
Elekta Unity MR Linac system
News | Radiation Oncology | January 30, 2020
January 30, 2020 — Elekta announced that it signed a contract wit